, Singapore

Daily Markets Briefing: STI up 0.6%

Index likely to stay more upbeat.

OCBC Investment Research said:

With the STI overcoming the 3280 immediate resistance with a 0.6% gain yesterday, this could potentially reverse the near-term downside momentum seen over the past two weeks.

The index is now more likely to maintain yesterday’s run and climb towards the 3320 key resistance in the days ahead.

Beyond that, the next obstacle lies at the 3400 psychological resistance. On the downside, 3280 is the newly established resistance-turned-support, followed by the next base at the 3230 key support.

Meanwhile, IG Markets Singapore noted:

In Singapore the STI gained 0.6% to leave it at 3289 this morning. Today could see a more positive vibe after last night’s upbeat US data.

Singapore saw industrial production plummet 16.6% year-on-year in February, though this did little to concern traders yesterday. The electronics sector saw a fall of 21.1%.

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

AI growth stalls as 78% cite weak data infrastructure
Confluent said firms are prioritising data streaming as they move AI projects from pilots into production.
Singapore emerges as key hub in Asia-Pacific’s next medtech wave
The city-state’s regulatory strength helps translate medical innovations into globally validated products.
Healthcare